United States · Resolution · HRES
H.Res. 279 (112th)
Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.
Introduced
25 May 2011
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
5 February 2024
Summary
Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications. Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 25 May 2011
Introduced in House (PDF)
Introduced in House · EN · 25 May 2011
Introduced in House
summary · EN · 25 May 2011
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/112th-congress/house-resolution/279
- Open data entity: https://api.congress.gov/v3/bill/112/hres/279